Bartonella henselae is the causative agent of cat scratch disease (CSD), which usually presents as a self-limiting lymphadenopathy. Occasionally, the bacteria will spread and be responsible for tissue and visceral involvement. Two B. henselae genotypes (genotypes I and II) have been described to be responsible for uncomplicated CSD on the basis of 16S rRNA sequence analysis. A type IV secretion system (T4SS) similar to the virulence-associated VirB system of Agrobacterium tumefaciens was recently identified in the B. henselae Houston-1 genotype I strain. We studied the correlations of the B. henselae genotypes with the clinical presentations and with the presence of T4SS. Isolates originated from CSD patients whose lymph nodes were prospectively analyzed. B. henselae genotype I was identified in 13 of 42 patients (30%). Among these, two teenage twins presented with hepatosplenic CSD and one immunocompetent adult presented with osteomyelitis. Genotype II was detected in 28 of 42 patie...
Cat scratch disease (CSD) typically presents as a benign lymphadenopathy in the proximal region of a cat's bite or scratch (5, 10, 15) . Because of its painless nature and poor response to antibiotic therapy, symptoms may suggest other, more serious diseases such as lymphoma and tuberculosis. Spontaneous resolution is nevertheless the rule and is an important element in the clinical diagnosis. CSD is mainly caused by Bartonella henselae, whose host reservoir is the cat (7, 17, 31) . B. henselae hides from the immune system inside erythrocytes and is transmitted from cat to cat via the bloodsucking flea Ctenocephalides felis (12, 37) .
Humans are infected incidentally, either directly by an injury from a cat or indirectly by cat fleas. In immunocompetent hosts, the disease is self-limited to CSD. Occasionally, the infection has an atypical presentation because the bacteria may spread and be responsible for endocarditis, encephalopathy, stellar retinitis, osteomyelitis, or systemic CSD with hepatic and splenic involvement (3, 5, 11, 24, 30, 36) . In immunocompromised hosts, the bacteria are often present in the blood and are involved in angioproliferative disorders such as bacillar angiomatosis and hepatic peliosis (33, 49) .
The diagnosis of CSD is mainly obtained clinically and epidemiologically. Cat contact can, however, be absent, which renders a diagnosis difficult (10) . Serology is a useful tool for the diagnosis of CSD, with reported sensitivities and specificities ranging from 14 to 100 and 34 to 100%, respectively (32, 39) . When available, histopathological examination usually reveals suppurative granulomas with central necrosis containing disintegrating neutrophils surrounded by palisading epithelioid cells and lymphocytes (5) . In some cases, granulomas may contain central homogeneous acellular material resembling the caseous necrosis encountered in Mycobacterium tuberculosis infection (22) . This picture may render the differential diagnosis from tuberculosis difficult. For these cases, PCR is very useful for confirmation of B. henselae infection. However, large variations in sensitivity (from 22 to 100%) have been reported in the literature (2, 4, 7, 14, 28, 34, 40, 46) . Two genotypes (genotypes I and II) have been described to be responsible for uncomplicated CSD on the basis of 16S rRNA sequence analysis (8) and correspond to two serotypes, Houston-1 and Marseille, respectively (26) . Epidemiological studies have suggested that genotype I has greater virulence (40, 42) . So far, no clinical studies have confirmed this hypothesis. Few B. henselae virulence factors have been characterized (16) . A virulence-associated type IV secretion system (T4SS) was recently described in B. henselae and Bartonella tribocorum (29, 43, 45) . T4SSs are used by several human pathogens, including Brucella suis, Bordetella pertussis, and Helicobacter pylori, to export effector molecules during infection (13) . In a B. tribocorum rat infection model, T4SS gene virB4 was shown to be essential for the establishment of intraerythrocytic infection (45) . Four putative T4SS genes (virB2, virB3, virB4 , and virB6) were identified in reference strain B. henselae Houston-1 genotype I, but their roles in B. henselae virulence are still unknown (29, 43) . So far, there has been no study of the correlation between the presence of virB genes and the clinical presentation of the infection.
In order to evaluate the role of Bartonella PCR in the everyday diagnosis of CSD, we undertook a prospective study within the framework of the Belgian Centers for Molecular Diagnosis, a structure established to evaluate the usefulness of PCR in clinical practice (http://www.uia.ac.be/cmd/). Clinical and laboratory data were collected for samples referred to us by clinicians. B. henselae DNA was detected by PCR amplification of a 414-bp fragment of the htrA (high-temperature requirement A) gene (1, 2). Our series comprised 46 patients with CSD and included three patients with visceral and osseous involvement as well as four familial cases. In addition, pathogenic isolates were investigated by studying their genotypes and the putative virulence-associated virB4 gene.
MATERIALS AND METHODS
CSD patients and samples. From March 2000 to May 2002, 47 lymph node biopsy specimens or aspirates from 46 patients clinically diagnosed with CSD were analyzed within the framework of the Centers for Molecular Diagnosis. Lymph nodes were frozen at Ϫ80°C upon receipt. The time of storage before DNA analysis ranged from 1 to 7 days. All CSD patients had a typical clinical presentation (regional lymphadenopathy in the absence of another obvious diagnosis) and in most cases a history of cat contact. A standardized questionnaire was completed for each CSD patient, with the following information obtained: gender, age, cat contact, the presence of a bite or a scratch, the date of onset of lymphadenopathy, the location and size of the lymphadenopathy, the presence of a papule or vesicle, the presence of hepato-or splenomegaly, the presence of fever and other symptoms, and previous antibiotic therapy. The data were supplemented with available laboratory results: histopathology and bacterial culture findings; acute-phase leukocyte counts; sedimentation rates; C-reactive protein levels; and Toxoplasma, cytomegalovirus, and Epstein-Barr virus serologies.
Non-CSD patients and samples. Forty-one lymph node biopsy specimens or aspirates from 41 non-CSD patients were used to test the specificity of the htrA PCR. Eight patients had lymphadenopathies of infectious origin. One was due to Streptococcus pyogenes, one was due to Staphylococcus aureus, and one was due to Cryptococcus neoformans. Two cases of lymphadenopathy were attributed to M. tuberculosis, and three were attributed to mycobacteria other than M. tuberculosis. One case of lymphadenopathy was attributed to Kikuchi disease on the basis of histopathological examination. Thirty-two cases of lymphadenopathy were of neoplastic origin.
Bacterial strains. B. henselae Houston-1 genotype I ATCC 49882 was used as a positive control for the PCRs. DNA extraction. DNA was extracted from frozen lymph node biopsy specimens or aspirates with the commercial Dneasy tissue kit (Qiagen, Westburg, The Netherlands). The procedures provided by the manufacturer were followed. Approximately 50 l of aspirate or 3 mm 3 of tissue was extracted. When no fresh material was available, DNA was extracted from 1 ml of the digested and decontaminated material used for mycobacterial culture or 1 ml of the Mycobacteria Growth Indicator Tube (MGIT) processed medium. The final elution volume was always 50 l.
DNA amplification. Primers CAT1 (5Ј-GATTCAATTGGTTTGAAGGAGG CT-3Ј) and CAT2 (5Ј-TCACATCACCAGGACGTATTC-3Ј) were used to amplify a 414-bp fragment of htrA as described by Anderson et al. (2) . For the genotype-specific amplification of B. henselae, primers BH1 (5Ј-CCGATAAAT CTTTCTCCCTAA-3Ј) and BH2 (5Ј-CCGATAAATCTTTCTCCAAAT-3Ј), each in combination with broad-host-range primer 16SF (5Ј-AGAGTTTGATC CTGG(CT)TCAG-3Ј), were used to amplify a 185-bp fragment of 16S rRNA (8) . Primers MBLG133 (5Ј-CCATCAGTCATCCCTGGTCGG-3Ј) and MBLG134 (5Ј-CTGAACCCGATCAGGAAGCCA-3Ј) amplify a 331-bp fragment extending from codon 146 to codon 256 of virB4 of the B. henselae Houston-1 strain (virB4Ј 146-256 ). PCR cycling consisted of 1 cycle of 10 min at 94°C; 50 cycles of 1 min at 94°C, 1 min at 57°C, and 1 min at 72°C; and then 1 cycle of 10 min at 72°C. Primers MBLG135 (5Ј-AAATCTTCTCTCGCGATAACG-3Ј) and MBLG136 (5Ј-AAGAGTAAAGCAGCGGCTAGT-3Ј) amplify a 254-bp fragment expanding from codon 273 to codon 357 of virB4 of the B. henselae Houston-1 strain (virB4Ј ). PCR cycling consisted of 1 cycle of 10 min at 94°C; 50 cycles of 1 min at 94°C, 1 min at 60°C, and 1 min at 72°C; and then 1 cycle of 10 min at 72°C. Primers MBLG137 (5Ј-TCCCAAGGCATCAATGGCTTT-3Ј) and MBLG138 (5Ј-AAGCCTTTGAAAAATGGACAA-3Ј) amplify a 174-bp fragment expanding from codon 480 to codon 537 of virB4 of the B. henselae Houston-1 strain (virB4Ј ). The PCR conditions were the same as those used for primers MBLG135 and MBLG136.
DNA amplification was carried out in 50-l reaction volume containing 5 l of 10ϫ reaction buffer II; 1 U of AmpliTaq Gold DNA polymerase (Applied Biosystems, Foster City, Calif.); 25 mM MgCl 2 ; the deoxynucleotide triphosphates dATP (200 M), dGTP (200 M), dCTP (200 M), and dUTP (600 M); primers (200 nM each); and 5 l of DNA at a dilution of 1/1 or 1/10. One unit of uracil-DNA-glycosylase (Roche Molecular Biochemicals, Mannheim, Germany) was added for the htrA PCR. The PCR products were separated on a 2% agarose gel and visualized by staining with ethidium bromide.
Southern blotting and hybridization with B. henselae-specific probe RH1 (5Ј-GGTGCGTTAATTACCGATCC-3Ј) were performed to confirm the specificity of the htrA PCR amplification product (2) . Hybridization was performed with a commercial DIG Nucleic Acid Detection kit (Roche Molecular Biochemicals) as described by the manufacturer.
Both positive and negative controls were included in each experiment. The positive control used to test the PCR mixture consisted of purified DNA from B. henselae Houston-1 ATCC 49882. The negative PCR control consisted of the reaction mixture without DNA template. The negative extraction control consisted of human joint tissue, which was handled in the same way as the clinical samples.
DNA sequencing. The PCR products were purified with the QIAquick Gel Extraction kit (Qiagen). Sequence analysis was performed by using the ABI Prism Big Dye Terminator Cycle Sequencing Ready Reaction kit with an automatic DNA sequencer (Applied Biosystems). The sequences were analyzed by using BLAST program-based sequence alignments.
B. henselae serology. Acute-phase serum samples were collected from 42 CSD patients. The time of sampling ranged from approximately 7 days to 6 months after the onset of the lymphadenopathy. Sera from 12 non-CSD patients were available. Serology was done by indirect immunofluorescence assay (IFA) on B. henselae slides commercialized by Focus Technologies (previously Microbiology Reference Laboratory, Cypress, Calif.), as described previously (9) . The cutoff values for a positive serology result were dilutions of 1/128 for immunoglobulin G (IgG) and 1/64 for IgM.
Statistical analysis. Fisher's exact test was used to compare proportions, and Student's t test for independent samples was used to compare the means for the data between the two groups of patients. Observed differences were considered significant when P was Ͻ0.05 by two-tailed tests.
Nucleotide sequence accession number. The GenBank nucleotide sequence accession number for the partial sequence of the virB4 homologue of B. elizabethae ATCC 49927 is AY289761.
RESULTS
Patient data. Forty-seven lymph node samples from 46 patients diagnosed with CSD were studied ( Table 1 ). The mean age of the patients was 28.8 years (age range, 3 to 81 years). Forty-three CSD patients had a history of cat contact, and 17 remembered being scratched or bitten by a cat; for 8 of the patients, clinicians reported the presence of an infectious lesion at the primary inoculation site. Twenty-four patients had received antibiotic therapy. Nine had presented with fever. Four patients had splenomegaly, and one patient had hepatomegaly. Three patients presented with complicated CSD. Patient 3 presented with CSD associated with osteomyelitis, and patients 2 and 7 presented with systemic CSD associated with hepatosplenic infection. Two pairs of siblings (patients 2 and 7
[sisters] and patients 11 and 12 [sisters]) were included in the study. The mean duration to sampling was 5.3 weeks, and the mean size of the lymph nodes was 3.4 cm. Thirty-one of the 47 yielded coagulase-negative staphylococci, and one culture (patient 36) yielded viridans group streptococci. Most of the cultures, including the one with S. aureus, were obtained after enrichment on Trypticase soy broth medium. All specimens analyzed (n ϭ 40) were negative for M. tuberculosis by culture.
Thirty-five of 42 lymph node specimens presented histopathological findings suggestive of CSD. A granulomatous inflammation with central caseous necrosis suggestive of tuberculosis was found in one lymph node specimen (patient 17). This sample was negative for M. tuberculosis by culture. Necrotic purulent material was found in three patients (patients (Table 1) . In two cases, no fresh lymph node tissue was available and so either the digested and decontaminated specimen (patient 7) or the MGIT medium that had been processed for M. tuberculosis culture (patient 3) was extracted. B. henselae DNA could be detected in both cases. Only 1 of the 47 specimens (patient 46) yielded a negative PCR result. The specificity of the htrA PCR was 100%. B. henselae DNA was not amplified from any of the 41 lymph node specimens originating from non-CSD patients ( Table 2) .
The sensitivity of serology was 47% for IgG production (Tables 1 and 2 ). Twenty of the 42 serum specimens analyzed yielded a titer greater than or equal to 128 (9 specimens had titers of 128, 5 specimens had titers of 256, 3 specimens had titers of 512, and 3 specimens had titers of Ͼ512). IgM production could be detected in only one patient. The specificity for IgG production was 66%. Four of the 12 non-CSD patients produced detectable IgG (titers, 128, 256, 512, and Ͼ512, respectively).
Genotype study and correlation with clinical data. A B. henselae genotype-specific PCR that allows amplification of a 185-bp 16S rRNA fragment was performed with the 43 PCRpositive lymph node specimens that were available (Table 1) .
Genotype II was identified in 29 lymph node specimens (67%). All samples originated from patients with typical CSD. None of the patients were siblings.
Genotype I was identified in 13 lymph node specimens (30%). Ten lymph node specimens originated from patients with typical CSD, and three originated from patients with atypical presentations. Two pairs of patients were siblings. Patients 11 and 12 (sisters) presented with typical CSD simultaneously. Patients 2 and 7 (twin sisters) concomitantly developed hepatosplenic CSD (M. Proesmans, I. Meyts, S. Woestyn, and K. De Boeck, submitted for publication). Genotype-specific PCR was performed with an inguinal lymph node specimen from each girl. Patient 3 developed cervical osteomyelitis and recurrent cervical lymphadenopathy. Genotype-specific PCR with the MGIT medium processed with the second lymph node specimen, as well as with the osseous tissue, confirmed the presence of B. henselae genotype I (53).
Both genotypes I and II were identified in one lymph node specimen (patient 42). Statistical analysis did not reveal significant epidemiological or biological differences between the 13 patients infected with B. henselae genotype I and the 28 patients infected with B. henselae genotype II (Table 3) .
virB4 secretion gene distribution. In order to study the distribution of T4SSs among the clinical B. henselae isolates, a first set of primers was designed to amplify part of the virB4 gene. Primers MBLG133 and MBLG134 enabled the amplification of a 331-bp region of virB4 (virB4Ј 146-256 ) (Table 1) .
To discriminate whether negative results were due to the absence of virB4 or to the virB4Ј 146-256 PCR itself, we designed a second set of primers. Primers MBLG135 and MBLG136 enabled the amplification of a 254-bp region of B. henselae virB4 (virB4Ј ). An amplification product was obtained from B. elizabethae DNA. The sequence of the virB4Ј PCR product (GenBank accession number AY289761) was highly homologous to the virB4Ј sequence of B. henselae (87% identity), which suggests the presence of a T4SS in B. elizabethae. When the annealing temperature was increased from 57 to 60°C, an amplification product was no longer obtained from , and virB4Ј 480-537 sequences of the isolates from the lymph node specimens and of the Marseille genotype II reference strain were determined. Twelve of 13 genotype I-positive lymph node specimens yielded sequences that were identical to each other but that differed at 10 positions from the sequence of the Houston-1 genotype I reference strain. Only one genotype I-positive lymph node specimen (patient 13) yielded sequences identical to the Houston-1 sequence. All genotype II-positive lymph node specimens (n ϭ 28) as well as the Marseille strain yielded sequences that were identical to each other but that differed at 11 positions from the Houston-1 sequence. The sequences observed in the lymph node of patient 13 (sequence pattern Houston-1), the 12 genotype I-positive lymph node specimens (sequence pattern I), and the genotype II-positive lymph node specimens and the Marseille strain (sequence pattern II) are presented in Fig. 1 . The genotype I-and II-positive lymph node specimens yielded two sequence patterns (patterns I and II), which confirms that patient 42 was coinfected with both genotypes.
DISCUSSION
PCR occupies a privileged position in CSD diagnosis, given the fastidious nature of B. henselae. However, retrospective studies have reported various sensitivities depending on the type of tissue (fresh or fixed), the target genes, or the diagnostic criteria that were used (2, 4, 7, 14, 28, 34, 40, 46) . Moreover, the routine use of B. henselae PCR in clinical practice has often been considered difficult. In Belgium, the Centers for Molecular Diagnosis have been set up in order to evaluate the usefulness of PCR in clinical practice (http://www.uia.ac.be/cmd/). Our laboratory was in charge of evaluating the B. henselae PCR. Lymph node specimens referred to us by clinicians were analyzed on a weekly basis. The diagnostic criteria for CSD were clinical and epidemiological. The htrA PCR was positive for 45 of the 46 (98%) CSD patients. The efficiency of the htrA PCR was not affected by the origin of the sample (biopsy specimen or pus aspirate) or by antibiotic therapy, as half of the patients had been treated. Contrary to the findings of Ridder et al. (35) , who observed a positive PCR result when they amplified a 296-bp fragment of 16S rRNA with primers p24E and p12B only during the first 6 weeks of lymphadenopathy, our PCR results did not depend on the duration of the illness. This might be due to the amplification of different target genes (16S rRNA and htrA) and the use of different PCR conditions. PCR with a specimen that had been digested and decontaminated for mycobacterial culture and a specimen that had been processed with MGIT medium enabled the detection of htrA. Since MGIT medium is usually kept for 42 days, such a procedure might be helpful for the retrospective diagnosis of CSD when clinical material is no longer available. FIG. 1 . Partial virB4Ј sequences. Houston, the sequences of the Houston-1 strain and the strain isolated from patient 13; I, the sequences of the genotype I strains isolated from patients 1 to 12; II, the sequences of the Marseille genotype II reference strain and the genotype II strains isolated from patients 14 to 40. Two specimens obtained from patient 31 at 3 and 20 weeks after the onset of lymphadenopathy, respectively, were analyzed. Numbers refer to the virB4 nucleotide positions starting from the first virB4 codon of B. henselae Houston-1. Asterisks indicate sequence variations that are responsible for amino acid modifications.
The specificity of the htrA PCR was 100%. None of the 41 lymph node specimens originating from non-CSD patients were htrA PCR positive.
Bartonella serology is often the first step that clinicians use for the confirmation of suspected CSD because it does not necessitate invasive procedures. We evaluated the IFA commercialized by Focus Technology (previously Microbiology Reference Laboratory) and observed a sensitivity and a specificity of 47 and 66% for IgG detection, respectively. When Sander et al. (41) evaluated this test with serum specimens from 42 German CSD patients, they obtained a sensitivity and a specificity of 93 and 73%, respectively. Our low sensitivity might have been because a number of the patients were infected with Marseille serotypes and the kit contains only the Houston-1 serotype. False-negative serology results for patients infected with serotype Marseille have already been shown (27) . However, we did not observe any differences in IgG production between the 28 patients infected with serotype Marseille (genotype II) and the 13 patients infected with serotype Houston-1 (genotype I) (P ϭ 0.2).
Our study completes the picture of the geographic distribution of the B. henselae genotypes detected in human lymph nodes in Europe (Fig. 2) . A virtual border can be drawn between northern countries (The Netherlands and Germany), where genotype I is predominant, and southern countries (e.g., France, Switzerland, and Belgium), where genotype II is more frequent (8, 40, 54 (40) . Clinical studies are still lacking to confirm this hypothesis. One study suggested that there is no variation in the clinical presentations caused by the different B. henselae genotypes (54) . This study, however, did not include any patient with an atypical CSD presentation. We report on the first correlation of B. henselae genotype I with atypical and familial CSD presentations.
Osteomyelitis in association with CSD is a very rare disease in immunocompetent adults (23, 25, 50, 52) . In our study the one patient with this condition was a 62-year old immunocompetent woman (patient 3) who presented with cervical osteomyelitis and two subsequent episodes of cervical lymphadenopathy. She owned many cats that often scratched her. Magnetic resonance imaging of the cervical region suggested tuberculosis. The diagnosis of CSD was established by using serology, histopathology, and htrA-and genotype-specific PCR analyses of both osseous tissue and lymph node tissue (53) . Hepatosplenic CSD is a systemic disease that is associated with microabscesses in the liver and the spleen. The chief complaints in children are prolonged fever and abdominal pain (3, 18) . The 12-year-old twins (patients 2 and 7) presented with cellulitis around an umbilical piercing, inguinal lymphadenopathy, high fever, and abdominal pain (Proesmans et al., submitted). Serology was negative, but contrast-enhanced computed tomography revealed small lucent areas in the liver and the spleen, suggestive of CSD. Histopathology and the htrAand genotype-specific PCRs of inguinal lymph node tissues confirmed the diagnosis. The girls wore fashionable short tops and allowed their kittens to play on their laps and lick their bellies. Whether the Bartonella organisms were inoculated via the kitten scratches or the pierced belly button is unknown. The finding of genotype I strains in these patients with atypical presentations suggests that genotype I has greater pathogenicity. However, this hypothesis requires further genotyping and clinical evaluations, given the low rate of occurrence of disseminated CSD in our series. CSD can affect several members of a family. Our series comprised two pairs of siblings (patients 2 and 7 and patients 11 and 12). Familial cases might be due to a common exposure to cats with high levels of bacteremia and the subsequent increase in the probability of transmission.
T4SSs have been identified in several pathogens. The prototypic T4SS is the VirB system of A. tumefaciens, which delivers oncogenic DNA to plant cells (13) . In Brucella suis, T4SS is required for survival and replication within the host macrophage (20, 47) . T4SS enables Bordetella pertussis to export the pertussin toxin and allows Helicobacter pylori to export the CagA protein (48, 51) . In a B. tribocorum rat infection model, T4SS is necessary for the establishment of intraerythrocytic infection (45) . Bartonella species share the peculiarity of causing intraerythrocytic infections in their human or animal reservoir hosts. T4SS might be involved in the endothelial cell invasion at the origin of the hemotropic seeding of the bacteria (16 (54) . Four nucleotide variations corresponded to amino acid modifications (Fig.  1) . In genotype II strains, alanine 179 of the Houston-1 strain was replaced by a threonine and alanine 516 was replaced by a glycine. In genotype I strains with pattern I, alanine 333 of the Houston-1 strain was replaced by a threonine and glycine 518 was replaced by an arginine. Amino acid variations among VirB4 proteins might simply be a consequence of the genetic diversity of B. henselae. They might also reflect functional differences between membrane transporters of both genotypes, e.g., with regard to the transport of different virulence factors. Export of different proteins by type III secretion, another secretion system used by human pathogens, has indeed been shown in clinical Pseudomonas aeruginosa isolates (19, 38) . Different secretion profiles correlated with different strain pathogenicities (38) . Similarly, B. henselae isolates might harbor different T4SSs and secrete different sets of virulence factors. Whether the three sequence patterns observed correspond to different virulence patterns has still to be demonstrated.
In conclusion, our study highlights the key position of the Bartonella PCR for the routine diagnosis of CSD. Genotyping studies showed a predominance of genotype II isolates among Belgian CSD patients. Our data point to a correlation of genotype I with atypical CSD presentations, an observation that requires further research. We report on the first case of coinfection with two B. henselae genotypes in human CSD. All human B. henselae isolates carried a virB4 gene. Partial sequence analysis suggested differences between the T4SSs of genotype I and genotype II strains.
